ADDEX THERAPEUTICS LTD (ADXN)

US00654J2069 - ADR

16.1  +0.69 (+4.48%)

Premarket: 7.63 -8.47 (-52.61%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
3.879M
36.89%		3.153M
-18.71%		1.445M
-54.18%		3.681M
154.75%
EBITDA
YoY % growth
-11.865M
16.86%		-15.158M
-27.76%		-20.197M
-33.24%		-10.346M
48.77%
EBIT
YoY % growth
-12.243M
16.17%		-15.506M
-26.65%		-20.52M
-32.34%		-10.344M
49.59%
Operating Margin
-315.62%-491.73%-1,420.12%-281.01%
EPS
YoY % growth
N/AN/A-9.54-10.12
-6.10%

All data in CHF

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CHF

Recent Earnings VS Estimates Surprises (CHF)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CHF)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -15.4%
RevenueN/A N/A 0% 0%